Syncona (SYNC) Share Price, News & Analysis

Company Overview

Syncona's purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams. Our balance sheet underpins our strategy, enabling us to take a long-term view as we look to improve the lives of patients with no or poor treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders.

Key Stats

• Today's Range: 93.90 to 95
• 50-Day Range: 79.70 to 94.50
• 52-Week Range: 77.32 to 126
• Volume: 219,158 shs
• Average Volume: 759,047 shs
• Market Capitalization: £585.09 million
• P/E Ratio: N/A
• Dividend Yield: 2.13%
• Price Target: N/A
• Consensus Rating: N/A

SYNC Stock Analysis - Frequently Asked Questions

How have SYNC shares performed this year?

Syncona's stock was trading at GBX 105.60 at the start of the year. Since then, SYNC shares have decreased by 11.0% and is now trading at GBX 94.

How do I buy shares of Syncona?

Shares of SYNC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Syncona own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Syncona investors own include Petrofac (PFC), Reckitt Benckiser Group (RKT), Barclays (BARC), B&M European Value Retail (BME), BP (BP), genedrive (GDR) and Vodafone Group Public (VOD).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:SYNC
• Previous Symbol: LON:BACT
• CIK: N/A
• Web: www.bacitltd.com
• Phone: 17168531362
• Fax: N/A
• Employees: 1,208
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX (2.71)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£16.90 million
• Net Margins: -310.53%
• Pretax Margin: N/A
• Return on Equity: -1.47%
• Return on Assets: 0.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.63
• Quick Ratio: 0.53

Sales & Book Value

• Annual Sales: £5.44 million
• Price / Sales: 107.53
• Cash Flow: GBX 80.03 per share
• Price / Cash Flow: 1.17
• Book Value: GBX 177.06 per share
• Price / Book: 0.53

Miscellaneous

• Outstanding Shares: 622,433,772
• Free Float: N/A
• Market Cap: £585.09 million
• Optionable: Not Optionable
• Beta: 0.26